Norman D. Lafrance - Net Worth and Insider Trading
Norman D. Lafrance Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Norman D. Lafrance owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of Norman D. Lafrance’s form 4 insider trades.
Insider Ownership Summary of Norman D. Lafrance
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PSTV | Plus Therapeutics Inc | 2021-11-11 | CHIEF MEDICAL OFFICER |
Norman D. Lafrance Trading Performance
Norman D. Lafrance Ownership Network
Norman D. Lafrance Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
Norman D. Lafrance is the CHIEF MEDICAL OFFICER of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and 10 percent owner Ag Postfinance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, Norman D. Lafrance made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 28,761 shares made by Robert P Lenk , a net purchase of 44,755 shares made by Greg Petersen , and a net purchase of 21,797 shares made by Howard Clowes .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Plus Therapeutics Inc (PSTV) were sold and 139,755 shares were bought by its insiders, resulting in a net purchase of 137,687 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
Norman D. Lafrance Mailing Address
Above is the net worth, insider trading, and ownership report for Norman D. Lafrance. You might contact Norman D. Lafrance via mailing address: Molecular Insight Pharmceuticals, Inc., 160 Second Street, Cambridge Ma 02142.